一、文章
1.Yutong Tan#, Dan Ye#, Cheng Qian, Juanjuan Shan* and Jiatao Li*, Yin yang 1: a potential regulator of immune related diseases and cancer immunity; Biochim Biophys Acta Rev Cancer, 2025,1880(5):189389.
2.Jiatao Li#, Juan Feng#, Ziyong Li#, Yuanli Ni, Limei Liu, Xia Lei, Zixuan Chai, Na Zhuang, Jiake Xu, Yongpeng He, Juanjuan Shan* and Cheng Qian*, B cell lymphoma 6 promotes hepatocellular carcinoma progression by inhibition tumor infiltrating CD4+T cell cytotoxicity through ESM1; npj Precision Oncology, 2024, 8(1):139.
3.Yadi Miao, Ziyong Li, Juan Feng, Xia Lei, Juanjuan Shan, Cheng Qian* and Jiatao Li*, The Role of CD4+T Cells in Nonalcoholic Steatohepatitis andHepatocellular Carcinoma; International Journal Of Molecular Sciences, 2024, 25(13): 6895.
4.Juan Feng#; Yongliang Liu#; Na Zhuang#; Zixuan Chai; Limei Liu; Cheng Qian; Jiatao Li * and Juanjuan Shan*; EDA-E7 activated DCs induces specific cytotoxic T lymphocyte immune responses against HPV expressing cervical cancer in human setting; Vaccines, 2023, 11:320.
5.Jiatao Li#, Cai Liang#, Kevin Y. Yang, Xiuzhen Huang, Mao Ying Han, Xisheng Li, Vicken W. Chan, Kathleen S. Chan; Di Liu; Zhan-Peng Huang; Bin Zhou*; Kathy O.Lui*; Specific ablation of CD4+ T-cells promotes heart regeneration in juvenile mice; Theranostics, 2020 Jun 29, 10(18):8018-8035.
6.Jiatao Li#; Xisheng Li#; Cai Liang; Lijun Ling; Zhiwei Chen; Chun Kwok Wong; Herman Waldmann; Kathy O. Lui*; Coreceptor blockade targeting CD4 and CD8 allows acceptance of allogeneic human pluripotent stem cell grafts in humanized mice; Biomaterials, 2020, 268: 0-120013.
7.Jiatao Li; Kevin Y Yang; Rachel Chun Yee Tam; Vicken W. Chan; Hui Yao Lan; Shohei Hori; Bin Zhou; Kathy O. Lui*; Regulatory T-cells regulate neonatal heart regeneration by potentiating cardiomyocyte proliferation in a paracrine manner; Theranostics, 2019, 9: 4324-4341.
8.Jiatao Li; Jean Tan; Mikaël M. Martino; Kathy O. Lui*; Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration ; Frontiers in Immunology, 2018, 9: 0-585.
9.Yongliang Liu, Guiqin Wang , Jiasi Zhang, Xue Chen, Huailong Xu, Gang Heng, Jun Chen, Yongchun Zhao, Jiatao Li, Yuanli Ni, Yingzi Zhang, Juanjuan Shan , Cheng Qian; CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia; Stem Cell Res Ther; 2021 Jan 25;12(1):86.
10.Yansen Xiao; Min Cong, Jiatao Li; Dasa He; Qiuyao Wu; Pu Tian; Yuan Wang; Shuaixi Yang; Chenxi Liang; Yajun Liang; Jili Wen; Yingjie Liu; Wenqian Luo; Xianzhe Lv; Yunfei He; Dong-dong Cheng; Tianhao Zhou; Wenjing Zhao; Peiyuan Zhang; Xue Zhang; Yichuan Xiao; Youcun Qian; Hongxia Wang; Qiang Gao; Qing-cheng Yang; Qifeng Yang; Guohong Hu; Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation; Cancer Cell, 2021, 39(3): 423-437.
11.Oscar M. Leung#; Jiatao Li#; Xisheng Li#; Vicken W. Chan; Kevin Y. Yang; Manching Ku; Lu Ji; Hao Sun; Herman Waldmann; Xiao Yu Tian; Yu Huang; James Lau; Bin Zhou; Kathy O. Lui*; Regulatory T Cells Promote Apelin-Mediated Sprouting Angiogenesis in Type 2 Diabetes; Cell Reports, 2018, 24(6):1610-1626.
二、承担和参与的科学研究项目
[1]国家自然科学基青年项目C类，调节性T细胞分泌Syndecan-2通过TGFβR/SMAD2/NANOG信号轴维持肝癌干细胞自我更新的分子机制（82403665）；项目负责人（2025.1-2027.12)；项目经费：30万元
[2]重庆市医学青年拔尖人才项目（YXQN202436），项目负责人（2024.7-2027.6），项目经费：20万
[3]重庆市科卫联合面上项目，新型疫苗EDA-HPV16 E7 重塑肿瘤微环境增强TCR-T 治疗宫颈癌疗效的功能及机制研究（2024MSXM027），项目负责人（2024.1-2025.12），项目经费：10万元
[4]重庆市自然科学基金面上项目，ESM1 通过抑制瘤内 T 细胞浸润及激活介导BCL6 促肝癌免疫逃逸的分子机制研究（CSTB2024NSCQ-MSX0841），项目负责人（2024.7-2027.6），项目经费：10 万元
[5]中央高校医工融合项目，调节性T细胞维持肝癌干细胞自我更新的机制研究，项目负责人(2021.7-2023.6)，项目经费：30万元
[6]重庆市绩效引导项目，BCL6抑制肿瘤浸润T细胞功能促进肝癌抗PD-L1治疗耐药的机制研究，项目负责人（2022.1-2023.12)，项目经费:20万元
[7]国家自然科学基金国际(地区)合作与交流项目，MEF2D 介导的肝脏免疫微环境重塑在炎症诱导肝癌发生中的作用及机制研究（82120108019），项目研究骨干（排名第二，2022.1-2026.12），项目经费：250万元
三、相关奖励与荣誉
[1] 2024年度重庆大学附属肿瘤医院科技创新先进个人二等奖
[2] 2023年重庆市科协岗位创新争先行动项目一等奖
